Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia
- Conditions
- Neonatal Hyperbilirubinemia
- Interventions
- Other: Massage therapyOther: Kinaesthetic stimulation
- Registration Number
- NCT05077787
- Lead Sponsor
- Asir John Samuel
- Brief Summary
Hyperbilirubinemia is the most common problem seen in neonates, owing to severe complications in their lifetime. The study design of the study is pretest - a posttest experimental design. Criterion-based purposive sampling will be used for recruiting the neonates. In the study neonates will be selected according to the selection criteria and will be allocated into two groups using computer-based randomization.The Intervention group - neonates will receive tactile and kinesthetic stimulation for 15 minutes for 3 consecutive days, 1 hour after feeding twice daily along with Phototherapy, Control group - Phototherapy alone will be given along with conventional NICU care. Total serum bilirubin will be assessed as outcome measures daily once. Transcutaneous bilirubin will be assessed after every intervention.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 68
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental Group Kinaesthetic stimulation Neonates recruited in experimental group will receive massage therapy and kinaesthetic stimulation for 15 minutes along with phototherapy for consecutive days . It will be given in three phases first massage therapy will be given for 5 minutes, followed by movement of limbs for 5 minutes and then again massage therapy will be repeated for 5 minutes. Experimental Group Massage therapy Neonates recruited in experimental group will receive massage therapy and kinaesthetic stimulation for 15 minutes along with phototherapy for consecutive days . It will be given in three phases first massage therapy will be given for 5 minutes, followed by movement of limbs for 5 minutes and then again massage therapy will be repeated for 5 minutes.
- Primary Outcome Measures
Name Time Method Total Serum Bilirubin (TSB) Changes in the Total Serum Bilirubin level will be measured at baseline and at the end of three days intervention It will measure total bilirubin level in blood of neonates
Transcutaneous Bilirubin (TcB) Changes in the Transcutaneous Bilirubin level will be measured daily for three days before and after intervention Transcutaneous Bilirubin will measure neonatal jaundice.
Weight Gain Changes in the weight will be measured at baseline and at the end of three days intervention Weight gain will evaluate the change in neonatal weight
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Civil Hospital
🇮🇳Ropar, Punjab, India